P-282: Addition of ixazomib to pomalidomide-dexamethasone improves progression-free survival for myeloma patients progressing on frontline lenalidomide: results of the randomized alliance study A061202
Titel:
P-282: Addition of ixazomib to pomalidomide-dexamethasone improves progression-free survival for myeloma patients progressing on frontline lenalidomide: results of the randomized alliance study A061202
Auteur:
Voorhees, Peter Suman, Vera Efebera, Yvonne Raje, Noopur Tuchman, Sascha Rodriguez, Cesar Santo, Katelyn Bova-Solem, Misty Carlisle, Destin Usmani, Saad McCarthy, Philip Richardson, Paul